Lepu Medical Technology (Beijing) Co., Ltd.

SZSE:300003.SZ

16.85 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 7,883.08510,609.44210,659.7358,038.6687,795.5296,356.3054,537.6433,467.7482,768.7171,668.6371,303.2681,015.92919.846770.101565.197393.879298.985175.338
Cost of Revenue 3,176.9683,983.2864,156.6372,653.7742,165.1951,732.1941,486.9141,354.1411,236.937608.276403.774212.033160.642131.529103.24984.38674.19850.942
Gross Profit 4,706.1176,626.1566,503.0985,384.8945,630.3344,624.1113,050.7292,113.6071,531.7811,060.361899.493803.888759.204638.572461.948309.494224.787124.396
Gross Profit Ratio 0.5970.6250.610.670.7220.7270.6720.610.5530.6350.690.7910.8250.8290.8170.7860.7520.709
Reseach & Development Expenses 800.744957.062907.941736.134543.914376.171234.75168.645110.11473.02172.33953.62632.84326.9640000
General & Administrative Expenses 270.515224.379293.524178.386211.259185.549115.47486.38670.47537.99144.32831.36522.02918.1757.65440.81633.98912.963
Selling & Marketing Expenses 1,624.6142,033.6862,109.1911,838.7832,171.6771,868.581,061.775638.057432.171341.342296.827226.093148.527114.34182.42970.47445.64729.699
SG&A 2,225.3022,258.0642,402.7152,017.1692,382.9372,054.1281,177.249724.443502.646379.333341.155257.458170.555132.51140.082111.2979.63542.662
Other Expenses -114.188552.19489.081457.581443.10631.46839.75928.99120.01720.10911.01813.4785.5823.3513.9481.190.811-0.433
Operating Expenses 3,140.2343,767.3173,799.7373,210.8843,369.9562,829.8981,725.4131,163.224810.229542.47483.293362.633248.688189.494141.266111.49279.98944.5
Operating Income 1,565.8832,623.1392,144.6022,149.1782,761.2561,442.4431,155.709864.215684.035516.864420.969466.463537.421469.346327.481200.515149.50479.939
Operating Income Ratio 0.1990.2470.2010.2670.3540.2270.2550.2490.2470.310.3230.4590.5840.6090.5790.5090.50.456
Total Other Income Expenses Net 12.976-11.3571.5554.136-698.001-320.302-129.848-59.421-20.61218.74715.75938.57632.48723.5710.7413.7035.517-0.39
Income Before Tax 1,578.8592,611.7822,146.1522,203.3132,063.2561,473.9111,195.468890.963700.94536.638431.959479.83543.003472.648331.423201.704150.31579.506
Income Before Tax Ratio 0.20.2460.2010.2740.2650.2320.2630.2570.2530.3220.3310.4720.590.6140.5860.5120.5030.453
Income Tax Expense 262.147367.094365.733326.235339.464219.037201.788144.255104.94984.40265.30976.50369.84562.00739.0650.5350.58915.905
Net Income 1,258.22,203.7791,719.3251,801.9331,725.3061,218.693899.085679.256520.891423.193361.645403.273473.158410.483292.212201.368149.72663.6
Net Income Ratio 0.160.2080.1610.2240.2210.1920.1980.1960.1880.2540.2770.3970.5140.5330.5170.5110.5010.363
EPS 0.681.220.961.010.970.680.510.390.320.260.220.250.290.250.190.140.120.13
EPS Diluted 0.681.210.951.010.970.680.510.390.320.260.220.250.290.250.190.140.120.13
EBITDA 2,169.663,361.5882,842.8352,916.0373,045.7472,238.6451,567.661,162.603897.796618497.483483.425571.813492.273344.896211.566151.43282.167
EBITDA Ratio 0.2750.3170.2670.3630.3910.3520.3450.3350.3240.370.3820.4760.6220.6390.610.5370.5060.469